-
Titration of Medical Therapy for Heart Failure With Reduced Ejection FractionSJ Greene, GC Fonarow, AD DeVore et al. -
Effect of Luseogliflozin on Heart Failure With Preserved Ejection Fraction in Patients With Diabetes MellitusK Ejiri, T Miyoshi, MUSCAT‐HF Study Investigators.
-
Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart FailureCK Nagaraju, EL Robinson, KR Sipido et al.
-
Clinical trial design and rationale of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) investigational device exemption clinical study protocolHeatley G, Sood P, MOMENTUM 3 Investigators.
-
Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart FailureMehra MR, Goldstein DJ, MOMENTUM 3 Investigators.
-
Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction"JG Howlett.
-
H2FPEF Score for Predicting Future Heart Failure in Stable Outpatients With Cardiovascular Risk FactorsSatoru Suzuki , K Kaikita, E Yamamoto et al.
-
How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)Pieske B Tschöpe C, de Boer RA et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
